Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 25,140 | 21,437 | 17,668 | 21,053 | 16,137 |
| Operating Income | -25,140 | -21,437 | -17,668 | -21,053 | -16,137 |
| Other Income | 2,699 | 2,639 | 1,182 | 1,801 | 1,671 |
| Pre-tax Income | -22,441 | -18,798 | -16,486 | -19,252 | -14,466 |
| Net Income Continuous | -22,441 | -18,798 | -16,486 | -19,252 | -14,466 |
| Net Income | $-22,441 | $-18,798 | $-16,486 | $-19,252 | $-14,466 |
| EPS Basic Total Ops | -0.59 | -0.52 | -0.73 | -0.87 | -0.66 |
| EPS Basic Continuous Ops | -0.59 | -0.52 | -0.73 | -0.86 | -0.66 |
| EPS Diluted Total Ops | -0.59 | -0.52 | -0.73 | -0.87 | -0.66 |
| EPS Diluted Continuous Ops | -0.59 | -0.52 | -0.73 | -0.86 | -0.66 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.52 | -0.73 | -0.86 | -0.66 |
| EBITDA(a) | $-26,093 | $-22,308 | $-18,021 | $-21,584 | $-16,746 |